Funding for this research was provided by:
British Heart Foundation (RE/18/6/34217, RE/18/6/34217)
Article History
Received: 29 September 2019
Accepted: 31 January 2020
First Online: 9 March 2020
Competing interests
: N.S. has consulted for Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Pfizer and Sanofi, and received grant support from Boehringer Ingeheim outside the submitted work. J.S. has received speakers’ honoraria from Janssen WA reports consultancy and sponsored lectures from Gilead, GlaxoSmithKline, Intercept IQVIA and UCB Pharma.